Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Leases (2019 - 2025)

Historic Current Leases for CorMedix (CRMD) over the last 7 years, with Q3 2025 value amounting to $844431.0.

  • CorMedix's Current Leases rose 41663.27% to $844431.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $844431.0, marking a year-over-year increase of 41663.27%. This contributed to the annual value of $167922.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that CorMedix reported Current Leases of $844431.0 as of Q3 2025, which was up 41663.27% from $177172.0 recorded in Q2 2025.
  • CorMedix's Current Leases' 5-year high stood at $844431.0 during Q3 2025, with a 5-year trough of $112323.0 in Q1 2021.
  • Over the past 5 years, CorMedix's median Current Leases value was $140578.0 (recorded in 2023), while the average stood at $180710.3.
  • As far as peak fluctuations go, CorMedix's Current Leases soared by 1022.41% in 2022, and later soared by 41663.27% in 2025.
  • Quarter analysis of 5 years shows CorMedix's Current Leases stood at $121368.0 in 2021, then rose by 11.23% to $135000.0 in 2022, then rose by 8.54% to $146531.0 in 2023, then increased by 14.6% to $167922.0 in 2024, then soared by 402.87% to $844431.0 in 2025.
  • Its Current Leases was $844431.0 in Q3 2025, compared to $177172.0 in Q2 2025 and $172495.0 in Q1 2025.